synthon


Also found in: Wikipedia.

synthon

(ˈsɪnˌθɒn)
n
(Chemistry) a component of a molecule to be synthesized that plays an active role in synthesis
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
Translations
synthon
Mentioned in ?
References in periodicals archive ?
(U.S.), Bayer HealthCare (Germany), Astellas Pharma/Agensys (Japan), Progenics Pharmaceuticals (U.S.), Heidelberg Pharma (Germany), Oxford BioTherapeutics (U.S.), Mersana Therapeutics (U.S.), and Synthon (U.S.).
Funds advised by UK-based private equity firm BC Partners have agreed to acquire a majority stake in Netherlands-based generics and hybrid medicines developer Synthon International Holding B.V.
M2 EQUITYBITES-July 8, 2019-BC Partners to Acquire Netherlands-Based Pharmaceutical Firm Synthon International
Ado-Trastuzumab (8-11) emtansine, T-DMI SYD985, Trastuzumab vc- Synthon BV seco-DUBA (37-39) Mersana ADC XMT-1522 Therapeutics (40) Zhejiang ADC ARX788 Medicine/Ambrx (41) ADC ADC ADCT-502 Therapeutics S.A.
Consulting or Advisory Role: Roche, Novartis, AstraZeneca, SERVER, Synthon, Puma Biotechnology, Pfizer, ADC Therapeutics, Tesaro
Food & Drug Administration (FDA) has granted Fast Track designation for Synthon Biopharmaceuticals' investigational anti-HER2 antibody-drug conjugate (ADC) [vic-]trastuzumab duocarmazine (SYD985).
Synthon Biopharmaceuticals, an international, science-cantered pharmaceutical company, has received Fast track designation from the US Food & Drug Administration (FDA) for its investigational anti-HER2 antibody-drug conjugate, (vic-) trastuzumab duocarmazine (SYD985), it was reported on Friday.
Nevertheless, the primary synthon, [[sup.11]C]C[O.sub.2], has been deployed successfully for the synthesis of [sup.11]C-compounds that contain carbonyl groups such as [[sup.11]C]carbamates [24, 25], amide [26], and [[sup.11]C]ureas [23,27-29].
launch, Mylan reported that partner Synthon has received marketing authorization approval in Europe for glatiramer acetate injection 40 mg/ml.
An N-acetylglucosaminide can be retro-synthetically disconnected to give an oxazolinium ion as a synthon (Fig.